Clinical Trial

OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer

Study acronym: SENT-OSNA
Recruiting
View on ClinicalTrials.gov →
Summary
Patients enrolled in the study will be randomized before surgery: in one study arm, the search for lymph node metastases in surgically removed sentinel lymph nodes will occur using the ultrastaging method (standard), while in the other arm it will be conducted using the OSNA method.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-16.
Status change: Not Yet Recruiting → Recruiting 2025-11-15
Trial Details
NCT Number NCT06935305
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborators: Sysmex Europe GmbH
Conditions Endometrial Cancer
Enrollment 1,922 participants
Start Date 2025-07-30
Primary Completion 2026-09-17 (estimated)
Study Completion 2029-03-17 (estimated)
Updated on ClinicalTrials.gov 2025-11-18